Antimicrobial functionalized genetically engineered spider silk

Biomaterials

Volumn 32, Issue 18, 2011, Pages 4255-4266

  Gomes, Sílvia C ^a,b   Leonor, Isabel B ^a   Mano, João F ^a   Reis, Rui L ^a   Kaplan, David L ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Antimicrobial activity; Bone tissue engineering; Cell viability; Recombinant proteins; Self assembly; Spider silk

Indexed keywords

ANTI-MICROBIAL ACTIVITY; BONE TISSUE ENGINEERING; CELL VIABILITY; RECOMBINANT PROTEINS; SPIDER SILK;

ASSEMBLY; BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CELL CULTURE; CIRCULAR DICHROISM SPECTROSCOPY; CROSSLINKING; DICHROISM; DNA SEQUENCES; ESCHERICHIA COLI; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GENETIC ENGINEERING; HUMAN ENGINEERING; MAMMALS; MICROORGANISMS; PEPTIDES; RATING; SELF ASSEMBLY; TISSUE ENGINEERING;

SILK;

ALPHA DEFENSIN; BIOMATERIAL; HEPCIDIN; HUMAN NEUTROPHIL DEFENSIN 2; HUMAN NEUTROPHIL DEFENSINS 4; HYBRID PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BETA SHEET; BIOENGINEERING; CANCER CELL CULTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; CROSS LINKING; ESCHERICHIA COLI; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; SILK; SPIDER; STAPHYLOCOCCUS AUREUS;

ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; SILK; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPIDERS; STAPHYLOCOCCUS AUREUS;

ARANEAE; ESCHERICHIA COLI; MAMMALIA; STAPHYLOCOCCUS AUREUS;

EID: 79955103835     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.040     Document Type: Article

References (77)

1. Hodgkinson R. Internal fixation of fractures of long bones with metallic devices. Med J Aust 1961, 48(1):691-693.
2. Osbon O., Lilly G., Thompson C. TJost. Bone grafts with surface decalcified allogeneic and particulate autologous bone: report of cases. J Oral Surg 1977, 35(4):276-284.
3. Kohna J., Welshb W.J., Knight D. A new approach to the rationale discovery of polymeric biomaterials. Biomaterials 2007, 28(29):4171-4177.
4. Williams D.J., Sebastine I.M. Tissue engineering and regenerative medicine: manufacturing challenges. IEE Proc Nanobiotechnol 2005, 156(6):207-210.
5. Santos M.I., Pashkuleva I., Alves C.M., Gomes M.E., Fuchs S., Unger R.E., et al. Surface-modified 3D starch-based scaffold for improved endothelialization for bone tissue engineering. J Mater Chem 2009, 19(24):4091-4101.
6. Santo V.E., Frias A.M., Carida M., Cancedda R., Gomes M.E., Mano J.F., et al. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 2009, 16(6):1392-1401.
7. Reis R.L., Neves N.M., Mano J.F., Gomes M.E., Marques A.P., Azevedo H.S. Natural-based polymers for biomedical applications 2008, Woodhead Publishing.
8. Mano J.F., Silva G.A., Azevedo H.S., Malafaya P.B., Sousa R.A., Silva S.S., et al. Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 2007, 4(17):999-1030.
9. Harris L.D., Kim B.-S., Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res B Appl Biomater 1998, 42(3):396-402.
10. Suh H. Recent advances in biomaterials. Yonsei Med J 1998, 39(2):87-96.
11. Huang J., Wong C., George A., Kaplan D.L. The effect of genetically engineered spider silk-dentin matrix protein 1 chimeric protein on hydroxyapatite nucleation. Biomaterials 2007, 28(14):2358-2367.
12. Yang L., Hedhammar M., Blom T., Leifer K., Johansson J., Habibovic P., et al. Biomimetic calcium phosphate coatings on recombinant spider silk fibres. Biomed Mater 2010, 5(4):1-10.
13. Foo C.W.P., Patwardhan S.V., Belton D.J., Kitchel B., Anastasiades D., Huang J., et al. Novel nanocomposites from spider silk-silica fusion (chimeric) proteins. Proc Natl Acad Sci USA 2006, 103(25):9428-9433.
14. Marr A.K., Gooderham W.J., Hancock R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 2006, 6(5):468-472.
15. Huang H.W. Action of antimicrobial peptides: two-state model. Biochemistry 2000, 39(29):8347-8352.
16. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999, 1462(1-2):55-70.
17. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother 1999, 43:1317-1323.
18. Befus A.D., Mowat C., Gilchrist M., Hu J., Solomon S., Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 1999, 163(2):947-953.
19. Grigat J., Soruri A., Forssmann U., Riggert J., Zwirner J. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human α-defensin family. J Immunol 2007, 179(6):3958-3965.
20. Aarbiou J., Verhoosel R.M., Van Wetering S., De Boer W.I., Van Krieken J.H., Litvinov S.V., et al. Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression In vitro. Am J Respir Cell Mol Biol 2004, 30(2):193-201.
21. Aarbiou J., Ertmann M., Wetering S., Noort P., Rook D., Rabe K.F., et al. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 2002, 72(1):167-174.
22. Murphy C.J., Foster B.A., Mannis M.J., Selsted M.E., Reid T.W. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993, 155(2):408-413.
23. Chavakis T., Cines D.B., Rhee J.-S., Liang O.D., Schubert U., Hammes H.-P., et al. Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J 2004, 18(11):1306-1308.
24. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000, 1(3):141-150.
25. Schneider J.J., Unholzer A., Schaller M., Schäfer-Korting M., Korting H.C. Human defensins. J Mol Med 2005, 83(8):587-595.
26. Smet K.D., Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005, 27(18):1337-1347.
27. Selsted M.E., Harwig S.S.L., Ganz T., Schilling J.W., Lehrer R.I. Primary structures of three human neutrophil defensins. J Clin Invest 1985, 76(4):1436-1439.
28. Jones D.E., Bevins C.L. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992, 267(15):23216-23225.
29. Pazgier M., Lubkowski J. Expression and purifcation of recombinant human α-defensins in Escherichia coli. Protein Expr Purif 2006, 49(1):1-8.
30. Wu Z., Cocchia F., Gentlesa D., Ericksena B., Lubkowskib J., DeVicoa A., et al. Human neutrophil a-defensin 4 inhibits HIV-1 infection in vit. FEBS Lett 2005, 579(1):162-166.
31. Krause A., Neitz S., Mägert H., Schulz A., Forssmann W., Schulz-Knappe P., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000, 480:147-150.
32. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276(11):7806-7810.
33. Koliaraki V., Marinou M., Samiotaki M., Panayotou G., Pantopoulos K., Mamalaki A. Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastori. Biochimie 2008, 90(5):1-10.
34. Wallace D.F., Jones M.D., Pedersen P., Rivas L., Sly L.I., Subramaniam V.N. Purification and partial characterisation of recombinant human hepcidin. Biochimie 2006, 88(1):31-37.
35. Zhang H., Yuan Q., Zhu Y., Ma R. Expression and preparation of recombinant hepcidin in Escherichia coli. Protein Expr Purif 2005, 41(2):409-416.
36. Xu M., Lewis R.V. Structure of a protein superfiber: spider dragline silk. Proc Natl Acad Sci USA 1990, 87(18):7120-7124.
37. Scheibel T. Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact 2004, 3(1):14-24.
38. Cao Y., Wang B. Biodegradation of silk biomaterials. Int J Mol Sci 2009, 10(4):1514-1524.
39. Guerreiro C.I.P.D., Fontes C.M.G.A., Gama M., Domingues L. Escherichia coli expression and purification of four antimicrobial peptides fused to a family 3 carbohydrate-binding module (CBM) from Clostridium thermocellum. Protein Expr Purif 2008, 59:161-168.
40. Ramos R., Domingues L., Gama M. Escherichia coli expression and purification of LL37 fused to a family III carbohydrate-binding module from Clostridium thermocellum. Protein Expr Purif 2010, 71(1):1-7.
41. Haynie S.L., Crum G.A., Doele B.A. Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin. Antimicrob Agents Chemother 1995, 39(2):301-307.
42. Bagheri M., Beyermann M., Dathe M. Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob Agents Chemother 2009, 53(3):1132-1141.
43. Appendini P., Hotchkiss J.H. Surface modification of poly(styrene) by the attachment of an antimicrobial peptide. J Appl Polym Sci 2001, 81(3):609-616.
44. Choa W.-M., Joshia B.P., Choa H., Lee K.-H. Design and synthesis of novel antibacterial peptide-resin conjugates. Bioorg Med Chem Lett 2007, 17(21):5772-5776.
45. Gabriel M., Nazmi K., Veerman E.C., Amerongen A.V.N., Zentner A. Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem 2006, 17(2):548-550.
46. Rabotyagova O., Cebe P., Kaplan D.L. Self-assembly of genetically engineered spider silk block copolymers. Biomacromolecules 2009, 10(2):229-236.
47. Yan S.-Z., Beeler J.A., Chen Y., Shelton R.K., Tang W.-J. The regulation of type 7 adenylyl cyclase by Its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD. J Biol Chem 2001, 276(11):8500-8506.
48. Hu X., Kaplan D., Cebe P. Determining beta-sheet crystallinity in fibrous proteins by thermal analysis and infrared spectroscopy. Macromolecules 2006, 39(18):6161-6170.
49. Arrondo J., Goñi F. Structure and dynamics of membrane proteins as studied by infrared spectroscopy. Prog Biophys Mol Biol 1999, 72(4):367-405.
50. Lehrer R.I., Rosenman M., Harwig S.S.S.L., Jackson R., Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991, 137(2):167-173.
51. Lancaster MV, Fields RD, inventors. antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents. USA Patent No. 5501959, 1996.
52. Foo C.W.P., Bini E., Huang J., Lee S.Y., Kaplan D.L. Solution behavior of synthetic silk peptides and modified recombinant silk proteins. Appl Phys A Mater Sci Process 2006, 82:193-203.
53. Rabotyagova O.S., Cebe P., Kaplan D.L. Role of polyalanine domains in β-sheet formation in spider silk block copolymers. Macromol Biosci 2010, 10(1):49-59.
54. Varkey J., Nagaraj R. Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines. Antimicrob Agents Chemother 2005, 49(11):4561-4566.
55. Kelly S.M., Jess T.J., Price N.C. How to study proteins by circular dichroism. Biochim Biophys Acta 2005, 1751(2):119-139.
56. Cerpa R., Cohen F.E., Kuntz I.D. Conformational switching in designed peptides: the helix/sheet transition. Fold Des 1996, 1(2):91-101.
57. Mamdal M., Nagaraj R. Antibacterial activities and conformations of synthetic α-defensin HNP-1 and analogs with one, two and three disulfite bridges. J Pept Res 2002, 59:95-104.
58. Bessa P.C., Pedro A.J., Klosch B., Nobre A., Van Griensven M., Reis R.L., et al. Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 p.oduced in Escherichia coli. Biotechnol Lett 2008, 30(1):15-21.
59. Long S., Truong L., Bennett K., Phillips A., Wong-Staal F., Ma H. Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. Protein Expr Purif 2006, 46(2):374-378.
60. Ericksen B., Wu Z., Lu W., Lehrer R.I. Antibacterial activity and specificity of the six human α-defensins. Antimicrob Agents Chemother 2005, 49(1):269-275.
61. Wilde C.G., Griffith J.E., Marra M.N., Snable J.L., Scott R.W. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem 1989, 264(5):11200-11203.
62. Harwig S.S., Park A.S. Lehrer. RI. Characterization of defensin precursors in mature human neutrophils. Blood 1992, 79:1532-1537.
63. Calamai M., Canale C., Relini A., Stefani M., Chiti F., Dobson C.M. Reversal of protein aggregation provides evidence for multiple aggregated states. J Mol Biol 2005, 346(2):603-616.
64. Hossain K.S., Nemoto N. Dynamic and static light scattering of dilute aqueous solutions of silk fibroin collected from Bombyx mori silkworms. Langmuir 1999, 15:4114-4119.
65. Ferraz M.P., Mateus A.Y., Sousa J.C., Monteiro F.J. Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts. J Biomed Mater Res A 2007, 81(4):994-1004.
66. Krisanapiboon A., Buranapanitkit B., Oungbho K. Biocompatability of hydroxyapatite composite as a local drug delivery system. J Orthop Surg 2006, 14(3):315-318.
67. Kanellakopoulou K., Giamarellos-Bourboulis E.J. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000, 59(6):1223-1232.
68. Shinto Y., Uchida A., Korkusuz F., Araki N., Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Jt Surg 1992, 74(4):600-604.
69. Bessa P.C., Balmayor E.R., Azevedo H.S., Nürnberger S., Casal M., Van Griensven M., et al. Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J Tissue Eng Regen Med 2010, 4(5):349-355.
70. Lia C., Veparia C., Jin H.-J., Kim H.J., Kaplan D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006, 27(16):3115-3124.
71. Ruszczak Z., Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev 2003, 55(12):1679-1698.
72. Schlapp M., Friess W. Collagen/PLGA microparticle composites for local controlled delivery of gentamicin. J Pharm Sci 2003, 92(11):2145-2151.
73. Luo Y., Kirker K.R., Prestwich G.D. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release 2000, 69(1):169-184.
74. Campoccia D., Montanaro L., Speziale P., Arciola C.R. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 2010, 31(25):6363-6377.
75. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nature 2003, 3:710-720.
76. Bruschi M., Pirri G., Giuliani A., Nicoletto S.F., Baster I., Scorciapino M.A., et al. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties. Peptides 2010, 31(8):1459-1467.
77. Numata K., Subramanian B., Currie H.A., Kaplan D.L. Bioengineered silk protein-based gene delivery systems. Biomaterials 2010, 30(29):5775-5784.